Anticoagulant therapy with rivaroxaban in a young patient with paroxysmal nocturnal hemoglobinuria

Clinical Case Reports

Francesco Dragoni¹  Flavia Chiarotti²  Laura Lombardi¹  Anna Paola Iori¹ 

[1] Thrombosis Center, Department of “Cellular Biotechnologies and Hematology”, “Sapienza” University, Rome, Italy;Department of “Biologia cellulare e Neuroscienze”, Istituto Superiore di Sanità, Rome, Italy

关键词: Anticoagulant therapy;    bleeding complication;    paroxysmal nocturnal hemoglobinuria;    rivaroxaban;    thrombosis;   

DOI  :  10.1002/ccr3.342

来源: Wiley

【 摘 要 】

Key Clinical Message

The new direct oral anticoagulants such us rivaroxaban, could play an important role in the anticoagulant treatment of patients with paroxysmal nocturnal hemoglobinuria where anticoagulant treatment is complex to run, since they have shown a reduction in serious bleeding complications compared to antithrombotic therapy with classical vitamin k antagonist.

【 授权许可】

CC BY-NC   
© 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.